Markets and expansion
Specialist access for populations that need it most.
Vitelo is designed for markets where the gap between patient need and specialist availability is widest. Our intended expansion focuses on South Asia and the Gulf — regions with large, growing populations, rising chronic disease burden, and significant constraints on specialist clinical capacity.
The access gap we are addressing
In many high-population markets, the ratio of specialists to patients is a fraction of what is considered adequate. Patients in secondary cities, rural areas, and underserved urban communities may wait months for a specialist appointment — or never receive one. Vitelo is designed to close that gap by connecting patients with remote specialists at the point of primary care, without requiring patients to travel to a specialist centre.
Intended expansion markets
Where Vitelo intends to operate
01
South Asia
Pakistan
Population: 240 million
Clinical and demographic context
Pakistan has one of the lowest specialist-to-population ratios in the region. The majority of specialists are concentrated in Karachi, Lahore, and Islamabad, leaving patients in secondary cities and rural areas with limited access to specialist care. Rising rates of diabetes, cardiovascular disease, and respiratory illness are increasing demand for specialist assessment at a time when specialist capacity is not growing at pace.
Vitelo opportunity
Vitelo's model is well suited to Pakistan's existing primary care infrastructure, where qualified general practitioners are present in secondary cities and smaller urban centres. A Vitelo partnership allows these facilities to offer specialist consultations without requiring patients to travel to a major city.
02
South Asia
India
Population: 1.4 billion
Clinical and demographic context
India has a large and growing middle class with rising expectations for healthcare quality, alongside a substantial population in Tier 2 and Tier 3 cities and rural areas where specialist access remains limited. The private healthcare sector is well developed in major cities but underserved in smaller urban and peri-urban markets.
Vitelo opportunity
Vitelo's partnership model is designed to work with India's established network of private hospitals and clinic groups in secondary cities, enabling them to offer specialist consultations that would otherwise require patients to travel to a metropolitan centre.
03
South Asia
Bangladesh
Population: 170 million
Clinical and demographic context
Bangladesh has a rapidly urbanising population with a growing private healthcare sector. Specialist access outside Dhaka is limited, and the burden of non-communicable disease — particularly diabetes and cardiovascular conditions — is increasing. The country has a strong mobile and digital infrastructure that supports telehealth delivery.
Vitelo opportunity
Vitelo's model addresses the concentration of specialists in Dhaka by enabling clinic groups and hospitals in Chittagong, Sylhet, and other secondary cities to offer specialist consultations to their patient populations.
04
Middle East
Gulf region
Population: 58 million
Clinical and demographic context
The Gulf Cooperation Council states have well-funded healthcare systems with high patient expectations and a significant expatriate workforce. Demand for specialist care is high, and health systems in the region are actively investing in digital health infrastructure. Employer-sponsored healthcare is a significant channel in markets such as the UAE and Saudi Arabia.
Vitelo opportunity
Vitelo's model is suited to the Gulf's employer-sponsored healthcare market, where companies seek to provide high-quality specialist access to employees — including those in locations not served by a specialist centre. Vitelo also offers a pathway for Gulf health systems seeking to expand specialist capacity without proportional increases in specialist headcount.
Our approach to market entry
Vitelo enters each market through clinical partnerships with established local facilities. We do not operate as a direct-to-consumer service. Each market entry is preceded by a regulatory and clinical governance assessment to ensure the Vitelo model can operate in compliance with local requirements.
01
Regulatory assessment
Before entering a new market, Vitelo conducts a regulatory assessment to understand the requirements for operating a telehealth service in that jurisdiction, including any requirements specific to AI-assisted clinical tools.
02
Local clinical partnership
Vitelo enters each market through a partnership with an established local clinical facility or health system. The local partner provides clinical credibility, patient access, and knowledge of the local regulatory environment.
03
Clinical governance alignment
Vitelo's clinical governance framework is adapted to meet local requirements while maintaining the core principles of clinician accountability, AI oversight, and patient safety that apply across all markets.
Market and partnership enquiries
If you represent a health system, clinic group, or investor with an interest in Vitelo's expansion into one of these markets, we welcome your enquiry.